Animalcare Group plc wins AIM Transaction of the Year Award at the AIM Awards 2017

We are delighted to announce that Animalcare Group plc has won AIM Transaction of the Year Award at the AIM Awards 2017. The award is given to a Company that “has been transformed by a single financial or commercial transaction during the period under review and thereby creating significant shareholder value.”

Find Out More About The Award


Animalcare is a sustainable pan-European animal health company working in a growing market

On 12 July 2017 shareholders approved the acquisition of Ecuphar NV to create a specialist pan-European animal health business with combined annual revenues of over £80m. The Enlarged Group now represents a growing, highly cash generative dividend paying company with a solid pipeline of new products.


Animalcare Group plc remains focussed on growing its veterinary business

Animalcare is a leading developer and supplier of veterinary pharmaceutical products with direct sales in seven countries, exporting to around 50 markets worldwide and owners of 50 licenced drugs, eight vaccines and over 100 care and nutraceutical products.

Animal Care

Investment Proposition

Our strategy has changed to reflect the success of Animalcare Ltd.

Over the last 10 years the strategy to license and sell generic veterinary medicines has delivered significant growth.

View Investment Proposition

Business Model

Delivering protectable products with increased margins.

Our development pipeline will focus on well-established veterinary medicines and reformulate them to create new range of enhanced generics.

View Business Model

Email Alerts

Email Subscription

Subscribe for the latest news and press releases

View Email Alerts

RSS Financial Calendar

  • Preliminary Results 2017 15/05/2018
  • Shareholder Roadshow 15/05/2018
  • 2018 AGM 27/06/2018